Ringers Irrigation

Sodium Chloride, Potassium Chloride, And Calcium Chloride Irrigant


Icu Medical Inc.
Human Prescription Drug
NDC 0990-6140
Ringers Irrigation also known as Sodium Chloride, Potassium Chloride, And Calcium Chloride Irrigant is a human prescription drug labeled by 'Icu Medical Inc.'. National Drug Code (NDC) number for Ringers Irrigation is 0990-6140. This drug is available in dosage form of Injection, Solution. The names of the active, medicinal ingredients in Ringers Irrigation drug includes Calcium Chloride - 33 mg/100mL Potassium Chloride - 30 mg/100mL Sodium Chloride - 860 mg/100mL . The currest status of Ringers Irrigation drug is Active.

Drug Information:

Drug NDC: 0990-6140
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Ringers Irrigation
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Sodium Chloride, Potassium Chloride, And Calcium Chloride Irrigant
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Icu Medical Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Injection, Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CALCIUM CHLORIDE - 33 mg/100mL
POTASSIUM CHLORIDE - 30 mg/100mL
SODIUM CHLORIDE - 860 mg/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:IRRIGATION
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: NDA
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 17 Sep, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 26 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: NDA017635
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:ICU Medical Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:847621
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:M4I0D6VV5M
660YQ98I10
451W47IQ8X
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Blood Coagulation Factor [EPC]
Calcium [CS]
Cations
Divalent [CS]
Increased Coagulation Factor Activity [PE]
Increased Large Intestinal Motility [PE]
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Osmotic Activity [MoA]
Osmotic Laxative [EPC]
Potassium Compounds [CS]
Potassium Salt [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0990-6140-091000 mL in 1 BOTTLE (0990-6140-09)17 Sep, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Ringers irrigation sodium chloride, potassium chloride, and calcium chloride irrigant sodium chloride sodium cation chloride ion potassium chloride potassium cation chloride ion calcium chloride calcium cation chloride ion water

Drug Interactions:

Drug interactions additives may be incompatible. consult with pharmacist, if available. when introducing additives, use aseptic technique, mix thoroughly and do not store.

Indications and Usage:

Indications and usage ringer’s irrigation, usp is indicated for all general irrigation, washing and rinsing purposes which permit use of a sterile, nonpyrogenic electrolyte solution.

Warnings:

Warnings for irrigation only. not for injection. irrigating fluids have been demonstrated to enter the systemic circulation in relatively large volumes; thus this irrigation must be regarded as a systemic drug. absorption of large amounts can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. the risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. the risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions. do not heat over 66° c (150° f).

Dosage and Administration:

Dosage and administration the dose is dependent upon the capacity or surface area of the structure to be irrigated and the nature of the procedure. when used as a vehicle for other drugs, the manufacturer’s recommendations should be followed. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. (see precautions .)

Contraindications:

Contraindications not for injection by usual parenteral routes. an electrolyte solution should not be used for irrigation during electrosurgical procedures.

Adverse Reactions:

Adverse reactions possible adverse effects arising from the irrigation of body cavities, tissues, or indwelling catheters and tubes are usually avoidable when proper procedures are followed. displaced catheters or drainage tubes can lead to irrigation or infiltration of unintended structures or cavities. excessive volume or pressure during irrigation of closed cavities may cause undue distention or disruption of tissues. accidental contamination from careless technique may transmit infection. should any adverse reaction occur, discontinue the irrigant, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

Drug Interactions:

Drug interactions additives may be incompatible. consult with pharmacist, if available. when introducing additives, use aseptic technique, mix thoroughly and do not store.

Use in Pregnancy:

Pregnancy: teratogenic effects. pregnancy category c. animal reproduction studies have not been conducted with ringer’s irrigation, usp. it is also not known whether ringer’s irrigation, usp can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. ringer’s irrigation, usp should be given to a pregnant woman only if clearly needed.

Pediatric Use:

Pediatric use: safety and effectiveness in pediatric patients have not been established.

Geriatric Use:

Geriatric use: clinical studies of ringer’s irrigation have not been performed to determine whether patients over 65 years respond differently from younger subjects. other reported clinical experience has not identified differences in responses between elderly and younger patients. in general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. this drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

Overdosage:

Overdosage in the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. (see warnings , precautions and adverse reactions .)

Description:

Description these products are sterile, nonpyrogenic solutions of electrolytes in water for injection intended only for sterile irrigation, washing and rinsing purposes. each 100 ml of ringer’s irrigation, usp contains: sodium chloride 860 mg; potassium chloride 30 mg; calcium chloride dihydrate 33 mg. the ph is 5.7 (5.0 — 7.5). the solution is isotonic (309 mosmol/liter, calc.) and has the following electrolyte content (meq/liter): na + 147.5; k + 4; ca ++ 4.5; cl − 156. the solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only for use as single-dose or short procedure irrigation. when smaller volumes are required the unused portion should be discarded. ringer’s irrigation, usp may be classified as a sterile irrigant, wash, rinse and pharmaceutical vehicle. calcium chloride, usp is chemically designated calcium chloride dihydrate (cacl 2 • 2h 2 o), white fragments or granules freely soluble in water. potassium chloride, usp is chemically designated kcl, a white granular powder freely soluble in water. sodium chloride, usp is chemically designated nacl, a white crystalline powder freely soluble in water. water for injection, usp is chemically designated h 2 o. the semi-rigid container is fabricated from a specially formulated polyolefin. it is a copolymer of ethylene and propylene. the container requires no vapor barrier to maintain the proper drug concentration. solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. exposure to temperatures above 25°c/77°f during transport and storage will lead to minor losses in moisture content. higher temperatures lead to greater losses. it is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

Clinical Pharmacology:

Clinical pharmacology ringer’s irrigation, usp exerts a mechanical cleansing action for sterile irrigation of body cavities, tissues or wounds, indwelling urethral catheters and surgical drainage tubes, and for washing, rinsing or soaking surgical dressings, instruments and laboratory specimens. it also serves as a vehicle for drugs used for irrigation or other pharmaceutical preparations. ringer’s irrigation, usp provides an isotonic irrigation with the same ionic constituents as ringer’s injection, usp, a modification of ringer’s solution (also called ringer’s mixture) originally used only as a topical physiologic salt solution. ringer’s irrigation, usp is considered generally compatible with living tissues and organs. calcium chloride in water dissociates to provide calcium (ca ++ ) and chloride (cl − ) ions. they are normal constituents of the body fluids and are dependent on various physiologic mechanisms for maintenance of balance between intake
and output. approximately 80% of body calcium is excreted in the feces as insoluble salts; urinary excretion accounts for the remaining 20%. potassium chloride in water dissociates to provide potassium (k + ) and chloride (cl − ) ions. potassium is the chief cation of body cells (160 meq/liter of intracellular water). it is found in low concentration in plasma and extracellular fluids (3.5 to 5.0 meq/liter in a healthy adult). potassium plays an important role in electrolyte balance. normally about 80 to 90% of the potassium intake is excreted in the urine; the remainder in the stools and to a small extent, in the perspiration. the kidney does not conserve potassium well so that during fasting or in patients on a potassium free diet, potassium loss from the body continues resulting in potassium depletion. sodium chloride in water dissociates to provide sodium (na + ) and chloride (cl − ) ions. sodium (na + ) is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. chloride (cl − ) has an integral role in buffering action when oxygen and carbon dioxide exchange occurs in the red blood cells. the distribution and excretion of sodium (na + ) and chloride (cl − ) are largely under the control of the kidney which maintains a balance between intake and output. water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). water balance is maintained by various regulatory mechanisms. water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (na + ) plays a major role in maintaining physiologic equilibrium.

Carcinogenesis and Mutagenesis and Impairment of Fertility:

Carcinogenesis, mutagenesis, impairment of fertility: studies with ringer’s irrigation, usp have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.

How Supplied:

How supplied ringer’s irrigation, usp is supplied in a single-dose 1000 ml semi-rigid irrigation container (ndc no. 0409–6140–09; ndc no. 0990-6140-09). icu medical is transitioning ndc codes from the "0409" to a "0990" labeler code. both ndc codes are expected to be in the market for a period of time. store at 20 to 25°c (68 to 77°f). [see usp controlled room temperature.] protect from freezing. revised: july, 2020 en-5962 manufactured for icu medical, inc., lake forest, illinois, 60045, usa

Package Label Principal Display Panel:

Principal display panel - 1000 ml bottle label 1000 ml rx only ndc 0990-6140-09 ringer's irrigation, usp 100 ml contains sodium chloride, 860 mg; potassium chloride 30 mg; calcium chloride, dihydrate 33 mg. 309 mosmol/liter (calc.). ph 5.7 (5.0 to 7.5). sterile, nonpyrogenic. not for injection. use only if clear and seal intact. warnings: do not heat bottle over 66°c (150°f). recommended storage: store at 20 to 25°c (68 to 77°f). [see usp controlled room temperature.] protect from freezing. see insert. single-dose container. contains no bacteriostat. discard unused portion. usual dosage: see insert. aqualite™ system manufactured for icu medical, inc., lake forest, illinois, 60045 usa icumedical rl -7292 lot exp principal display panel - 1000 ml bottle label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.